Literature DB >> 17663423

Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab.

B Moum, Z Konopski, K F Tufteland, J Jahnsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17663423     DOI： 10.1002/ibd.20230

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  9 in total

Review 1.  Management of arthropathy in inflammatory bowel diseases.

Authors:  Rosario Peluso; Francesco Manguso; Maria Vitiello; Salvatore Iervolino; Matteo Nicola Dario Di Minno
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

2.  Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

Authors:  Susana Rodrigues; Susana Lopes; Fernando Magro; Hélder Cardoso; Ana Maria Horta e Vale; Margarida Marques; Eva Mariz; Miguel Bernardes; Joanne Lopes; Fátima Carneiro; Guilherme Macedo
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 3.  Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.

Authors:  Ora Shovman; Shalev Tamar; Howard Amital; Abdulla Watad; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2017-10-23       Impact factor: 2.980

Review 4.  Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors:  Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 5.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

Review 6.  Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease.

Authors:  Frank Hoentjen; Ad A van Bodegraven
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

7.  Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry.

Authors:  Katja Perdan-Pirkmajer; Alojzija Hočevar; Žiga Rotar; Janez Žibert; Vera Ferlan Marolt; Filip Gučev; Matija Tomšič
Journal:  Rheumatol Int       Date:  2012-09-07       Impact factor: 2.631

8.  Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report.

Authors:  Rogerio Serafim Parra; Marley Ribeiro Feitosa; Vanessa Foresto Machado; Leandra Naira Zambelli Ramalho; Jose Joaquim Ribeiro da Rocha; Omar Feres
Journal:  J Med Case Rep       Date:  2015-10-30

Review 9.  Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.

Authors:  Parth Shah; Vinay Sundaram; Einar Björnsson
Journal:  Hepatol Commun       Date:  2020-01-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.